Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Ceribell, Inc. filings on SEC EDGAR ↗
Ceribell Director William W. Burke Sells $479K of Stock
William W. Burke, Director, sold 18,000 shares of Ceribell, Inc. at $26.58 to $27.48 a share (average $26.64) in 2 transactions, worth $479K in total on Nov 12, 2026. Shares held after the trade: 23,022 (-4.8%).
Ceribell Director Joseph Michael Taylor Sells $278K of Stock
Joseph Michael Taylor, Director, sold 10,200 shares of Ceribell, Inc. at $27.22 a share, worth $278K in total on Nov 9, 2026. Shares held after the trade: 38,278 (-21.0%).
Raymond Woo, CTO, sold 4,887 shares of Ceribell, Inc. at $26.96 a share, worth $132K in total on Nov 2, 2026. Shares held after the trade: 203,118 (-2.3%).
Ceribell, Inc. reported total revenue of $29.3 million for the third quarter of 2026, representing a 30% increase year-over-year. However, the company experienced a net loss of $21.4 million for the quarter and $60.4 million for the first nine months of 2026, driven by significant increases in sales, marketing, and R&D expenses.
Ceribell reported Q3 2026 total revenue of $29.3 million, a 30% year-over-year increase driven by record account additions and same-store utilization growth. The company achieved a 90% gross margin and ended the period with $117.5 million in cash and marketable securities. Key operational milestones included the full launch of its delirium monitoring solution and receiving FDA 510(k) clearance for new EEG analysis features.
Term
Q3 2026
“Our third quarter results reflect new highs in account additions and utilization within our existing account base, demonstrating the strength of our core seizure business as a durable growth engine. With the full launch of our delirium monitoring solution and the coming introduction of our new hardware platform, we are well positioned for a pivotal 2027 as we advance our mission to establish EEG as a new vital sign.”
Raymond Woo, CTO, sold 4,887 shares of Ceribell, Inc. at $24.38 a share, worth $119K in total on Oct 1, 2026. Shares held after the trade: 203,118 (-2.3%).